UBS O'Connor’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-2,272,475
Closed -$202M 537
2017
Q1
$202M Buy
+2,272,475
New +$187M 3.41% 4
2015
Q2
Sell
-24,750
Closed -$2.49M 1017
2015
Q1
$2.49M Buy
24,750
+13,949
+129% +$1.41M 0.02% 378
2014
Q4
$1.09M Sell
10,801
-47,622
-82% -$4.75M 0.02% 350
2014
Q3
$5.62M Buy
+58,423
New +$5.54M 0.1% 206

Other funds holding MJN

UBS O'Connor's MJN Position: Q2 2017 in Review

UBS O'Connor sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 2,272,475 shares — an estimated $202M sold.

UBS O'Connor first reported a position in MJN in Q3 2014 and held it in 4 quarters. The position peaked at $202M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • UBS O'Connor reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • UBS O'Connor sold 2,272,475 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $202M.
  • UBS O'Connor first reported a position in Mead Johnson Nutrition Company in Q3 2014 and held it in 4 quarters.
  • UBS O'Connor's Mead Johnson Nutrition Company position peaked at $202M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on UBS O'Connor's 13F filing for Q2 2017, filed 14 Aug 2017.